Ocular Inflammation Associated with Cataract Surgery

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-04-01
Clinical Trial Update: Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial [Phase 4]
Phase 4 randomized trial comparing Bromfenac ophthalmic solution to Nepafenac ophthalmic suspension for ocular inflammation after cataract s…